Inspire Medical Systems Inc (NYSE:INSP) — Market Cap & Net Worth
Market Cap & Net Worth: Inspire Medical Systems Inc (INSP)
Inspire Medical Systems Inc (NYSE:INSP) has a market capitalization of $1.22 Billion ($1.22 Billion) as of June 22, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #8224 globally and #2345 in its home market, demonstrating a 0.78% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Inspire Medical Systems Inc's stock price $42.61 by its total outstanding shares 28813153 (28.81 Million). Review Inspire Medical Systems Inc total liabilities to assess the company's total debt and financial obligations.
Inspire Medical Systems Inc Market Cap History: 2018 to 2026
Inspire Medical Systems Inc's market capitalization history from 2018 to 2026. Data shows growth from $1.22 Billion to $1.23 Billion (6.79% CAGR).
Index Memberships
Inspire Medical Systems Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P Small-Cap 600 Index
SML
|
$1.64 Trillion | 0.38% | #433 of 602 |
Weight: Inspire Medical Systems Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Inspire Medical Systems Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Inspire Medical Systems Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.91x
Inspire Medical Systems Inc's market cap is 2.91 times its annual revenue
Latest Price to Earnings (P/E) Ratio
18.27x
Inspire Medical Systems Inc's market cap is 18.27 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $1.22 Billion | $50.59 Million | -$21.83 Million | 24.06x | N/A |
| 2019 | $2.14 Billion | $82.05 Million | -$33.24 Million | 26.06x | N/A |
| 2020 | $5.42 Billion | $115.38 Million | -$57.20 Million | 46.97x | N/A |
| 2021 | $6.63 Billion | $233.39 Million | -$42.04 Million | 28.40x | N/A |
| 2022 | $7.26 Billion | $407.86 Million | -$44.88 Million | 17.79x | N/A |
| 2023 | $5.86 Billion | $624.80 Million | -$21.15 Million | 9.38x | N/A |
| 2024 | $5.34 Billion | $802.80 Million | $53.51 Million | 6.65x | 99.82x |
| 2025 | $2.66 Billion | $911.98 Million | $145.42 Million | 2.91x | 18.27x |
Competitor Companies of INSP by Market Capitalization
Companies near Inspire Medical Systems Inc in the global market cap rankings as of June 22, 2026.
Key companies related to Inspire Medical Systems Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #147 globally with a market cap of $153.73 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #207 globally with a market cap of $117.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #247 globally with a market cap of $101.86 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #147 | Abbott Laboratories | NYSE:ABT | $153.73 Billion | $88.41 |
| #207 | Stryker Corporation | NYSE:SYK | $117.79 Billion | $307.80 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #247 | Medtronic PLC | NYSE:MDT | $101.86 Billion | $79.34 |
Inspire Medical Systems Inc Historical Marketcap From 2018 to 2026
Between 2018 and today, Inspire Medical Systems Inc's market cap moved from $1.22 Billion to $ 1.23 Billion, with a yearly change of 6.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.23 Billion | -53.80% |
| 2025 | $2.66 Billion | -50.25% |
| 2024 | $5.34 Billion | -8.87% |
| 2023 | $5.86 Billion | -19.24% |
| 2022 | $7.26 Billion | +9.48% |
| 2021 | $6.63 Billion | +22.31% |
| 2020 | $5.42 Billion | +153.46% |
| 2019 | $2.14 Billion | +75.64% |
| 2018 | $1.22 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 22nd, 2026 the market cap of Inspire Medical Systems Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.22 Billion USD |
| MoneyControl | $1.22 Billion USD |
| MarketWatch | $1.22 Billion USD |
| marketcap.company | $1.22 Billion USD |
| Reuters | $1.22 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develop… Read more